Short Interest in Olympus Co. (OTCMKTS:OLYMY) Expands By 768.3%

Olympus Co. (OTCMKTS:OLYMYGet Free Report) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 6,721 shares, a growth of 768.3% from the August 15th total of 774 shares. Based on an average trading volume of 49,485 shares, the short-interest ratio is presently 0.1 days.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group cut Olympus from a “buy” rating to a “neutral” rating in a research report on Monday, June 15th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.

Read Our Latest Research Report on OLYMY

Olympus Stock Performance

Shares of Olympus stock traded up $0.51 during midday trading on Friday, hitting $12.80. The company had a trading volume of 20,015 shares, compared to its average volume of 94,333. The company has a 50 day moving average of $12.13 and a 200 day moving average of $10.77. Olympus has a 52-week low of $8.08 and a 52-week high of $13.73.

About Olympus

(Get Free Report)

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.

See Also

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.